Related Experiment Video
Updated: Jan 21, 2026

Single Molecule Analysis of Laser Localized Psoralen Adducts
Published on: April 20, 2017
ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2
Mariangela Sabatella1,2, Alex Pines1,2, Jana Slyskova1,3
1Department of Molecular Genetics, Erasmus MC, 3015 GE, Rotterdam, The Netherlands.
Abstract:
The effectiveness of many DNA-damaging chemotherapeutic drugs depends on their ability to form monoadducts, intrastrand crosslinks and/or interstrand crosslinks (ICLs) that interfere with transcription and replication. The ERCC1-XPF endonuclease plays a critical role in removal of these lesions by incising DNA either as part of nucleotide excision repair (NER) or interstrand crosslink repair (ICLR). Engagement of ERCC1-XPF in NER is well characterized and is facilitated by binding to the XPA protein. However, ERCC1-XPF recruitment to ICLs is less well understood. Moreover, specific mutations in XPF have been found to disrupt its function in ICLR but not in NER, but whether this involves differences in lesion targeting is unknown. Here, we imaged GFP-tagged ERCC1, XPF and ICLR-defective XPF mutants to investigate how in human cells ERCC1-XPF is localized to different types of psoralen-induced DNA lesions, repaired by either NER or ICLR. Our results confirm its dependence on XPA in NER and furthermore show that its engagement in ICLR is dependent on FANCD2. Interestingly, we find that two ICLR-defective XPF mutants (R689S and S786F) are less well recruited to ICLs. These studies highlight the differential mechanisms that regulate ERCC1-XPF activity in DNA repair.
Insights
The ERCC1-XPF endonuclease repairs DNA damage from chemotherapy drugs. Its recruitment to interstrand crosslinks (ICLs) depends on FANCD2, and specific mutations impair this targeting.
Area of Science:
- Molecular Biology
- DNA Repair Mechanisms
- Cancer Therapeutics
Background:
- Chemotherapeutic drugs induce DNA damage, including interstrand crosslinks (ICLs), which are critical targets for cancer treatment.
- The ERCC1-XPF endonuclease is essential for repairing DNA lesions via nucleotide excision repair (NER) and ICL repair (ICLR).
- While ERCC1-XPF's role in NER is understood, its recruitment to ICLs and the impact of specific mutations on its targeting remain unclear.
Purpose of the Study:
- To investigate the localization of ERCC1-XPF and its mutants to psoralen-induced DNA lesions repaired by NER or ICLR in human cells.
- To elucidate the differential mechanisms regulating ERCC1-XPF activity in distinct DNA repair pathways.
Main Methods:
- Utilized GFP-tagged ERCC1, XPF, and ICLR-defective XPF mutants for live-cell imaging.
- Visualized the localization of these proteins to psoralen-induced DNA lesions.
- Analyzed the dependence of ERCC1-XPF recruitment on XPA for NER and FANCD2 for ICLR.
Main Results:
- Confirmed ERCC1-XPF dependence on XPA for NER.
- Demonstrated that ERCC1-XPF engagement in ICLR is dependent on FANCD2.
- Showed that two ICLR-defective XPF mutants (R689S and S786F) exhibit reduced recruitment to ICLs.
Conclusions:
- ERCC1-XPF localization and function are differentially regulated in NER and ICLR pathways.
- FANCD2 is crucial for recruiting ERCC1-XPF to ICLs, highlighting a distinct mechanism from NER.
- Specific XPF mutations affecting ICLR also impair its targeting to ICLs, suggesting a link between recruitment and repair efficiency.
Related Concept Videos
Frequency-dependent Selection
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
DNA Packaging
Drug Dependence
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...

